The interaction of proteins with polysaccharides represents a major and challenging topic in glycobiology, since such complexes mediate fundamental biological mechanisms. An affinity capillary electrophoresis method has been developed to evidence the complex formation and to determine the binding properties between an anticoagulant polysaccharide of marine origin, fucoidan, and a potential target protein, antithrombin. This method is a variant of zonal electrophoresis in the mobility shift format. A fixed amount of protein was injected into a capillary filled with a background electrolyte containing the polysaccharide in varying concentrations. The effective mobility data of the protein were processed according to classical linearization treatments to obtain the binding constant for the polysaccharide/antithrombin complex. The results indicate that fucoidan binds to antithrombin in a 1:1 stoichiometry and with an affinity depending on the molecular weight of the polysaccharide. For heparin, the binding constant obtained similarly is in accordance with the literature. This is the first report showing the implementation of a capillary electrophoresis method contributing to the mechanistic understanding of the biological activities of fucoidan and providing evidence for the complex formation between fucoidan and the protein inhibitor of the coagulation antithrombin.
keeping the consumption of carbohydrates and proteins to a minimum. Affinity capillary electrophoresis (ACE) has been introduced for the analysis of receptor-ligand interactions and the determination of binding constants (4, 5, 6) . The basic principle involves the change in charge to mass ratio (inducing a change in electrophoretic mobility) of an analyte through buffer solutions containing dissolved ligands. Scatchard analysis can then be performed to derive the binding constant and interaction stoichiometry (7, 8) . This approach is then well suited for the study of highly anionic polysaccharides for which a large difference in electrophoretic mobility is expected between the free target protein and the complex. This experimental protocol inherits various advantages of CE such as resolving power, ease of automation, high speed, absence of solid phase and non-denaturating conditions. Given our interest in the study of bioactive anionic polysaccharides, all these attractive performances prompted us to develop a CE method for the quantitative characterization of complex formation between sulfated polysaccharides and target proteins.
Algal fucoidan is a sulfate-based polysaccharide endowed with important properties in several biological mammalian systems (9) . Numerous biological activities have been ascribed for this polysaccharide, like anticoagulant and antithrombotic activities as being an activator of both antithrombin and heparin cofactor II (10, 11) , anti-inflammatory (12, 13) , antitumoral (14) , contraceptive (15) and antiviral (16) . Its molecular structure is partially elucidated (17, 18) , and therefore the structural basis of its biological properties remains to be established (19) . It is generally assumed that these biological properties are related to the capability of fucoidan to achieve specific interactions with target proteins. Concerning the anticoagulant activity, previous studies showed that fucoidan catalysed the activity of the serine proteinase inhibitors antithrombin and heparin cofactor II suggesting a binding of fucoidan to these serpins (20) . The complex formed between the anticoagulant sulfated polysaccharide heparin and antithrombin (21) can be considered as the prototype of the carbohydrate-protein complex for this study. In this work, we developed and applied an ACE method in order to investigate the capability of fucoidan to make a complex with antithrombin, and to determine its interaction parameters, i.e. the dissociation constant and stoichiometry.
MATERIALS AND METHODS

Materials.
Benzyl alcohol was purchased from Aldrich (Saint Quentin Fallavier, France). The fucoidan used in this study was extracted from the algae Ascophyllum nodosum and purified by size-exclusion chromatography as previously published (22, 23) . The following fucoidan fractions of different molecular weight were studied i.e. F1 (Mr 2,900), F2 (Mr 5,000) and F3 (Mr 10,000). Heparin (H108, Mr 15,800) from porcine intestinal source was provided as a sodium salt by SANOFI-Recherche (Gentilly, France). Human antithrombin (AT, Mr 58,000) was purchased from BIOGENIC (Maurin, France) and was stocked at -20°C as a 6.25 mg/mL solution in water. Other chemicals and reagents were obtained from current commercial sources at the highest level of purity available. All buffers and solutions were prepared with ultra pure water produced by an Alpha Q laboratory water purification system (Millipore, Milford, MA). were from Beckman (Gagny, France). Samples were introduced in the hydrodynamic mode.
The whole injection protocol allowing for both the protein and the neutral marker to be introduced was as follows (see also Evaluation of the exact length to detector and data treatment. Because of the four successive steps of the injection protocol, the migration length of the analytes did not exactly correspond to the capillary inlet-to-detection window distance, l. The corrected migration lengths l corr NM and l corr P for the neutral marker and the protein respectively were calculated as follows:
l corr NM = l -(l 2 + l 3 + l 4 ) -0.5 l 1 [1] l corr P = l -l 4 -0.5 l 3 [2] where l 1 through l 4 stand for the zone lengths corresponding to the four hydrodynamic injection steps, and numbered in the order of introduction. These lengths were calculated according to equation [3] :
where d c , P o , t o , η and L stand for the internal capillary diameter, the injection pressure, the injection time, the viscosity of the separation electrolyte and the total length of the capillary, respectively.
Presented in Table 1 are the four successive injection steps, and the corrected migration lengths calculated from the injection parameters. These corrected lengths were considered to calculate the electrophoretic mobility of the analytes. Finally, the apparent (m app ), electroosmotic (m eo ) and electrophoretic (m ep ) mobilities were calculated from the classical equations :
m app = l corr P . L / V . t a p p [5] m ep = m app -m e o [6] where V is the applied voltage, t NM and t app denote the experimentally measured migration times of the neutral marker and of the protein, respectively.
RESULTS AND DISCUSSION
Principle and conditions of the electrophoretic assay. The purpose of this work was to Furthermore, as the apparent mobilities of the protein and of the complex are higher than the mobility of the polysaccharide, the protein migrates through the capillary in an electrolyte
containing the polysaccharide at a concentration that can be considered constant throughout the capillary.
Theoretical determination of the binding constants. The general ACE approach exploits the changes in electrophoretic mobilities of an analyte due to complex formation upon addition of increasing amounts of a ligand to a separation electrolyte. Detailed theoretical treatments and discussions on experimental methods and considerations on the estimation of binding constants can be found in the literature (25, 26) . Fundamentally, these methods were adapted from similar chromatographic procedures. Basically, a molecular association between an analyte and a ligand can be described by the general rectangular hyperbolic form of a binding isotherm :
The dependent variable, y, is the experimentally measured response of the analyteligand system (in the present case, the effective electrophoretic mobility). The variable x in equation [7] is the concentration of free ligand, whereas d, e and f are constants related to the properties of the analyte, ligand and complex, and including the binding constant and binding stoichiometry information.
By analogy with the antithrombin-heparin complex which follows a 1:1 stoichiometry (27), a 1:1 complexation equilibrium model was selected ab initio to describe the antithrombin-fucoidan complex. The complexation equilibrium can then be simply schematized as :
The formation constant relative to this equilibrium is :
where 
which, by introducing Eq [8] , can be rearranged to yield the binding isotherm equation :
In order to determine the binding constant of the complex, this equation can be transformed into linearized forms, referencing the measured effective mobility μ p eff of the protein to the absolute mobility of the free protein μ p 0 or of the complex μ c o , as shown in Table 2 . In addition to the binding constant, it should be noted that the x-reciprocal, y-reciprocal and the double reciprocal methods provide the absolute mobility of the complexed protein μ c o (as far as μ p 0 is easily measured directly), whereas the linearized isotherm method requires the μ c o value to be directly determined experimentally beforehand. A good estimation of the μ c o value can be obtained by measuring the limiting effective mobility of the protein at high polysaccharide concentration.
For the four plotting methods listed in Table 2 where the experimental uncertainty is greater (25, 26) . In this study, we determined the K f
(1/K d ) value according to the four methods previously described, so as to evaluate the quality of the experimental measurements.
Finally, the experimental verification of the linearity of these plots will ascertain the concordance with a 1:1 binding system. It is worth remembering that, more generally, when the assumption of a 1:1 complexation is not made, a Scatchard plot, which is equivalent to a x-reciprocal plot, can give an indication of the stoichiometry of the complexation. for heparin (27) . The effective electrophoretic mobility of the protein μ p eff was systematically calculated for each experiment using Eqs 4 to 6. The four linearization methods described previously were then applied to these sets of mobility data. Table 2 : Linearized forms of the binding isotherm recommended for the determination of binding constants using ACE methods in the mobility shift format.
Method name Plotting method
To be determined by experiment directly figure 2 . Plotting methods as mentioned in Table 2 . 
